Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine and Valproate for Opiate Withdrawal
NCT00367874Phase 4Completed
- Sponsor
- Sørlandet sykehus
- Start
- Feb 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine, valproic acid in opioid use disorder (OUD), substance withdrawal syndrome, sponsored by Sørlandet sykehus. Started Feb 2003; status: completed.
02
Drugs
buprenorphinevalproic acid
03
Conditions
opioid use disorder (OUD)substance withdrawal syndrome
Beyond the preview
Go deeper on NCT00367874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367874.